Trials / Completed
CompletedNCT01462643
Efficacy and Tolerability of LAS41004 Formulations in a Non-occlusive Psoriasis Plaque Test
A 22 Day Controlled, Randomized Clinical Study (PPT) Investigating the Anti-psoriatic Efficacy and the Tolerability of an Ointment Containing a Retinoid and a Steroid in Different Concentrations
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 22 (actual)
- Sponsor
- Almirall, S.A. · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the exploratory study is to compare dose related effects of LAS41004 formulations in a non-occlusive PPT.
Detailed description
Going for a non-occlusive application design will allow to draw practical conclusions as being similar to a real treatment situation (compared with a occluded design to maximise effects)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | LAS41004 | once daily, topical ointment, 100 microgram per day |
Timeline
- Start date
- 2011-08-01
- Primary completion
- 2011-09-01
- Completion
- 2011-09-01
- First posted
- 2011-10-31
- Last updated
- 2011-10-31
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT01462643. Inclusion in this directory is not an endorsement.